GPhC’s Pharmacy Concerns Resolution Service

The GPhC has confirmed it’s going to trial a new route for dealing with concerns about pharmacy professionals, separate from the formal fitness to practise process. Previously I wrote about FtP concerns rising by a third in a single year, and then about cases now taking about three years to resolve on average, so it’s no surprise the regulator’s looking at ways to take pressure off that system.

The new service is called the Pharmacy Concerns Resolution Service, and the GPhC told the Pharmaceutical Journal on 10 November that it’ll launch as a proof of concept in early 2027, working with the law firm Nockolds to build it out. The idea is to give concerns that don’t need a full regulatory investigation somewhere else to go, rather than funnelling everything through the same FtP route regardless of how serious it actually is.

Dionne Spence, the GPhC’s chief enforcement officer, said on LinkedIn that almost 90% of the concerns the regulator receives don’t need a formal investigation, though “every concern does deserve an opportunity to be heard and handled properly.” That’s a big share of the workload potentially moving to a lighter-touch process, and it chimes with something I saw plenty of as an inspector in an old life, where most things that landed on my desk during a visit were better sorted through the pharmacy’s own complaints process or a conversation with the superintendent than referred up to the regulator.

The GPhC was careful to stress this won’t touch cases involving real risks to patient safety, professional conduct or public trust, which stay in the regulatory process as before. Spence described the new service as a way of moving non-regulatory concerns out of the Council’s oversight so the formal process can focus on what genuinely needs it, and the Royal College of Pharmacy’s Tase Oputu welcomed the move too, noting that a drawn-out complaint can be genuinely hard on someone’s wellbeing whichever way it’s eventually resolved.

For your own governance there isn’t much to act on yet, since this is a proof of concept still over a year from any real launch, but it’s worth watching how the GPhC ends up drawing the line between what stays formal and what gets diverted.

Check out the full story here: Regulator to trial independent complaints review service

Shahzad Ahmad
Written by Shahzad Ahmad
Pharmacy consultant and former GPhC inspector. Connect on LinkedIn →
Next
Next

MedSafetyWeek: Why Pharmacy Yellow Card Reporting Matters